Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0022568 (
keratitis
)
5,133
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Staphylococcus aureus is one of the most common pathogens causing
keratitis
.
Surfactant protein D
(
SP-D
) plays a critical role in host defense and innate immunity. In order to investigate the role of
SP-D
in ocular S. aureus infection, the eyes of wild-type (WT) and
SP-D
knockout (
SP-D
KO) C57BL/6 mice were infected with S. aureus (10(7) CFU/eye) in the presence and absence of cysteine protease inhibitor(E64).Bacterial counts in the ocular surface were examined 3, 6, 12, 24 hrs after infection. Bacterial phagocytosis by neutrophils and bacterial invasion in ocular epithelial cells were evaluated quantitatively. S. aureus-induced ocular injury was determined with corneal fluorescein staining. The results demonstrated that
SP-D
is expressed in ocular surface epithelium and the lacrimal gland; WT mice had increased clearance of S. aureus from the ocular surface (p<0.05) and reduced ocular injury compared with
SP-D
KO mice. The protective effects of
SP-D
include increased bacterial phagocytosis by neutrophils (p<0.05) and decreased bacterial invasion into epithelial cells (p<0.05) in WT mice compared to in
SP-D
KO mice. In the presence of inhibitor (E64), WT mice showed enhanced bacterial clearance (p<0.05) and reduced ocular injury compared to absent E64 while
SP-D
KO mice did not. Collectively, we concluded that
SP-D
protects the ocular surface from S. aureus infection but cysteine protease impairs
SP-D
function in this murine model, and that cysteine protease inhibitor may be a potential therapeutic agent in S. aureus
keratitis
.
...
PMID:Protective Role of Surfactant Protein D in Ocular Staphylococcus aureus Infection. 2639 97